Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...

The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

Human health is strongly intertwined with the health of the microbiome. A large number of studies have shown that the human ...

Mohs surgery significantly improved recurrence, metastasis, and mortality rates in patients with primary high-stage cutaneous ...

The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...

Neoadjuvant chemoimmunotherapy for muscle-invasive bladder cancer (MIBC) followed by risk-adapted therapy led to high rates ...

The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Luminescent gold nanoparticles (L-AuNPs) represent a novel class of luminescent nanomaterials that have attracted ...